Balchem Corporation
BCPC
$162.06
-$3.06-1.85%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 985.93M | 964.54M | 953.68M | 942.38M | 932.39M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 985.93M | 964.54M | 953.68M | 942.38M | 932.39M |
| Cost of Revenue | 632.95M | 621.68M | 617.48M | 617.52M | 616.34M |
| Gross Profit | 352.98M | 342.86M | 336.21M | 324.86M | 316.05M |
| SG&A Expenses | 135.27M | 131.52M | 134.81M | 143.83M | 138.76M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 786.03M | 770.56M | 769.09M | 777.57M | 770.86M |
| Operating Income | 199.91M | 193.99M | 184.60M | 164.81M | 161.53M |
| Income Before Tax | 185.33M | 177.54M | 166.45M | 155.24M | 147.82M |
| Income Tax Expenses | 42.58M | 41.00M | 37.98M | 33.70M | 31.04M |
| Earnings from Continuing Operations | 142.75 | 136.54 | 128.48 | 121.54 | 116.78 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 142.75M | 136.54M | 128.48M | 121.54M | 116.78M |
| EBIT | 199.91M | 193.99M | 184.60M | 164.81M | 161.53M |
| EBITDA | 243.91M | 239.02M | 232.29M | 215.66M | 215.59M |
| EPS Basic | 4.40 | 4.21 | 3.97 | 3.76 | 3.62 |
| Normalized Basic EPS | 3.61 | 3.46 | 3.25 | 2.83 | 2.71 |
| EPS Diluted | 4.36 | 4.17 | 3.93 | 3.72 | 3.59 |
| Normalized Diluted EPS | 3.58 | 3.43 | 3.22 | 2.80 | 2.69 |
| Average Basic Shares Outstanding | 129.72M | 129.67M | 129.48M | 129.41M | 129.15M |
| Average Diluted Shares Outstanding | 130.82M | 130.79M | 130.61M | 130.54M | 130.23M |
| Dividend Per Share | 0.87 | 0.87 | 0.87 | 0.79 | 0.79 |
| Payout Ratio | 19.81% | 20.71% | 19.91% | 21.04% | 21.90% |